Pureに変更を加えた場合、すぐここに表示されます。

Fingerprint Shinnosuke Ikemuraが取り組む研究トピックをご確認ください。これらのトピックラベルは、この人物の研究に基づいています。これらを共に使用することで、固有の認識が可能になります。

  • 19 同様のプロファイル
Non-Small Cell Lung Carcinoma Medicine & Life Sciences
Lung Neoplasms Medicine & Life Sciences
irinotecan Medicine & Life Sciences
Mutation Medicine & Life Sciences
Lung Medicine & Life Sciences
Epidermal Growth Factor Receptor Medicine & Life Sciences
Protein-Tyrosine Kinases Medicine & Life Sciences
Squamous Cell Carcinoma Medicine & Life Sciences

ネットワーク 最近の共同研究。丸をクリックして詳細を確認しましょう。

研究成果 2010 2019

  • 407 引用
  • 11 h指数
  • 29 Article
1 引用 (Scopus)

A phase II trial of induction of erlotinib followed by cytotoxic chemotherapy for EGFR mutation-positive non-squamous non-small cell lung cancer patients

Tani, T., Naoki, K., Yasuda, H., Arai, D., Ishioka, K., Ohgino, K., Yoda, S., Nakayama, S., Satomi, R., Terai, H., Ikemura, S., Sato, T. & Soejima, K., 2019 1 1, (Accepted/In press) : : Cancer Chemotherapy and Pharmacology.

研究成果: Article

Chemotherapy
Non-Small Cell Lung Carcinoma
Cells
Drug Therapy
Mutation
6 引用 (Scopus)

Efficacy of afatinib or osimertinib plus cetuximab combination therapy for non-small-cell lung cancer with EGFR exon 20 insertion mutations

Hasegawa, H., Yasuda, H., Hamamoto, J., Masuzawa, K., Tani, T., Nukaga, S., Hirano, T., Kobayashi, K., Manabe, T., Terai, H., Ikemura, S., Kawada, I., Naoki, K. & Soejima, K., 2019 1 1, : : Lung Cancer. 127, p. 146-152 7 p.

研究成果: Article

Insertional Mutagenesis
Epidermal Growth Factor Receptor
Non-Small Cell Lung Carcinoma
Exons
Therapeutics

Molecular dynamics simulation-guided drug sensitivity prediction for lung cancer with rare EGFR mutations

Ikemura, S., Yasuda, H., Matsumoto, S., Kamada, M., Hamamoto, J., Masuzawa, K., Kobayashi, K., Manabe, T., Arai, D., Nakachi, I., Kawada, I., Ishioka, K., Nakamura, M., Namkoong, H., Naoki, K., Ono, F., Araki, M., Kanada, R., Ma, B., Hayashi, Y. および8人, Mimaki, S., Yoh, K., Kobayashi, S. S., Kohno, T., Okuno, Y., Goto, K., Tsuchihara, K. & Soejima, K., 2019 5 14, : : Proceedings of the National Academy of Sciences of the United States of America. 116, 20, p. 10025-10030 6 p.

研究成果: Article

公開
Molecular Dynamics Simulation
Lung Neoplasms
Mutation
Pharmaceutical Preparations
Protein-Tyrosine Kinases

Monomer preference of EGFR tyrosine kinase inhibitors influences the synergistic efficacy of combination therapy with cetuximab

Oashi, A., Yasuda, H., Kobayashi, K., Tani, T., Hamamoto, J., Masuzawa, K., Manabe, T., Terai, H., Ikemura, S., Kawada, I., Naoki, K. & Soejima, K., 2019 1 1, : : Molecular cancer therapeutics. 18, 9, p. 1593-1601 9 p.

研究成果: Article

Dimerization
Protein-Tyrosine Kinases
Non-Small Cell Lung Carcinoma
Lung Neoplasms
Therapeutics
5 引用 (Scopus)

A case of pulmonary adenocarcinoma showing rapid progression of peritoneal dissemination after immune checkpoint inhibitor therapy

Shinozaki, T., Iwami, E., Ikemura, S., Matsuzaki, T., Nakajima, T., Hashimoto, K. & Terashima, T., 2018 5 31, : : BMC Cancer. 18, 1, 620.

研究成果: Article

Carboplatin
Paclitaxel
Skin Diseases
Ascites
Non-Small Cell Lung Carcinoma